Particle.news
Download on the App Store

Kirsty Gallacher Awaits Scan After Radiotherapy for Inoperable Acoustic Neuroma

The result will determine whether doctors keep the tumour under surveillance or move to a higher‑risk intervention.

Overview

  • Gallacher was first diagnosed with a benign acoustic neuroma after sudden right‑ear hearing loss in the summer of 2021, when doctors treated her as an emergency.
  • She told Vanessa Feltz on Wednesday that she had radiotherapy last year and now has an MRI scheduled that will show if the treatment has stopped or shrunk the growth.
  • Clinicians say the radiotherapy’s goal is to arrest or reduce tumour growth rather than remove it, and its success is not guaranteed so the scan is key to assessing progress.
  • The tumour has left Gallacher effectively deaf in her right ear and with worse tinnitus; clinicians have suggested a hearing aid but she has not adopted one and she now relies on lip‑reading in noisy settings.
  • An acoustic neuroma is a benign nerve‑sheath tumour beside the hearing nerve, and the MRI outcome will guide whether care remains watchful monitoring or moves toward riskier surgery or more treatment.